Phio Pharmaceuticals Corp (PHIO)

[sick nam vet]

Agreed,love to see these corrupt mm's and hedgies take right up their azzzzzz.Good Luck.

[trendzone]

Also added more at that price, corrupt Street and their shorting algo machines of criminal activity,most likely behind the grind down to these levels, looking forward for they get their asses handed to them.

[sick nam vet]

Added 1.18s, can't believe they pushed it this low.

[trendzone]

Total corrupted criminal MM and others engaged in after hours activities.

[sick nam vet]

Nice movement today!!!

[trendzone]

Another big run up this week would be the icing on the cake,that the shorting creeps would choke on.

[Laloo77]

Agree 100%. This is just getting started here.

[trendzone]

Just high lighted on one of the top lists of being naked shorted stocks,by hedge funds known for stock manipulation, and holding large short positions, also the same corrupt manipulators that are getting their butts handed to them on their VE))((RU naked short today that's up over 200% today, they will get hit over here again before this week ends.

[BeasTrader]

What happen to the pumper

[MASTERULTRA]

RSI IS 90 YOU GUYS ARE STUPID AS HELL..
OVERBOUGHT WATCH THIS RETRACED.

[knrorrel]

PHIO is maybe the next SBF_m to $9 ?

[knrorrel]

good stock https://www.marketwatch.com/investing/stock/phio?mod=over_search

[knrorrel]

$10 WOULD BE GREAT
THX

[logsplitter]

I hope you guys all need to cover, let's get this baby to ten bucks this week

[knrorrel]

$3.50 would be great , would be a good start

[Harbor6460]

3.50 or 1.70 open. Which will it be

[02opida]

ocket shipped

[PStockPickz]

Well that was fun. Have a good weekend all

[TheFinalCD]

2.85 is 52W hi, its amazing how one day regained a whole year of price decline

just amazing

$PHIO

[knrorrel]

monday maybe $5+ ?

[knrorrel]

looks after more https://www.nasdaq.com/market-activity/stocks/phio/real-time

[JusDePomme]

Shitttt I saw u post 1.37 at the time plan buy but I think up alot....now after hour double....damm

[TheFinalCD]

tHANK yOU

[knrorrel]

PHIO looks fantastic and might even be heading towards $3 in after hours, she just has volume and today is day one...... she's in monster mode - just fantastic

imo

[spindog]

Smart money…. Sending prayers to you and your family

[spindog]

Once again I was too chicken to jump in Earlier on…. Missed out on huge gains… Hoping for a pullback for Monday mornings entry

[stock1ace1]

Blast off

[TheFinalCD]

rocket shipped

[02opida]

MARLBOROUGH, Mass., Jan. 11, 2022 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced that it has received regulatory clearance to start a clinical trial with its lead product candidate, PH-762. The Company was granted the clinical trial authorization (CTA) by the French National Agency for the Safety of Medicines and Health Products (ANSM - L'Agence nationale de sécurité du médicament et des produits de santé) to proceed with a first-in-human clinical trial for PH-762 to treat patients with melanoma at the Gustave Roussy Institute. The Company expects to dose the first patient in the first quarter of 2022.

Logo - https://mma.prnewswire.com/media/786567/Phio_Pharmaceuticals_Logo.jpg

"Receiving this clinical trial authorization is an important milestone for Phio as it is the first clinical study of a new generation of immuno-oncology therapeutics based on our INTASYL self-delivering RNAi platform," said Dr. Gerrit Dispersyn, President and CEO of Phio. "This milestone is the first of several planned for this year, as we continue to accelerate our development of our clinical and preclinical product candidates."

PH-762 activates immune cells to better recognize and kill cancer cells. It does so by reducing the expression of PD-1, a clinically validated target for immunotherapy. PD-1 is expressed by T cells and prevents them from killing other cells, including cancer cells. Therefore, reducing PD-1 expression can reduce the ability of cancer cells to evade T cell detection and killing. In preclinical studies, PH-762 has demonstrated robust and durable efficacy in various in vivo tumor models, and importantly has shown that it can elicit an abscopal effect or systemic immune response after local administration.

The Company's first clinical trial with PH-762 will be a Phase 1b study to evaluate the safety, tolerability, pharmacokinetics and anti-tumor activity of PH-762 in a neoadjuvant setting in subjects with advanced melanoma. There are currently no neoadjuvant treatment options approved for these patients. The study features a dose escalation of PH-762 monotherapy and is designed to allow for a data driven evaluation of the recommended Phase 2 dose.

[up2nuttn]

Jack what are your thoughts here?

[up2nuttn]

I read they may be working on partnership

[up2nuttn]

anybody home?

[up2nuttn]

Lets go

[ADVFN_abullman]

Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021.
https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021-301365371.html

[Hobbydigger-53]

Hi folks, a nice chance for a rebound to a fair value. In at 1,65 with a trade speculation to 3.50 - 3.90 at first. but with some patience.
Good luck

[ClayTrader]

* * $PHIO Video Chart 05-07-2021 * *

Link to Video - click here to watch the technical chart video

[TradingForProfit]

Phio Pharmaceuticals Awarded U.S. Patent #10,900,03 'Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1'

[Stockexpertpro]

PHIO 70% of the Daily Volume is being sold Short

http://shortvolumes.com/?t=phio

[Stockexpertpro]

PHIO 50-55% Cancer Survival VS just 10-15% With Chemo that in its self is HUGE plus Chemo does horrible damage to the body

[Stockexpertpro]

150 Million Volume on a 4.6 Million Share Float since its latest Reverse Stock Split. also we have Joe Biden Coming with the Cancer Moonshot intiative. We also have a conference Dec 3rd thats in 2 days going back this stock has a history of HUGE Runs in Dec Ultra Low Float Stock trades the ENTIRE Float on UP Days and comes back down on next to no volume on down days has for months now.... MACD Ready to turn positive on the weekly chart for the first time in YEARS This has SuperNova Potential written all over it with a gap to fill on the chart at over 60$+ per share reminds me of BPTH 2$ to 73$ in days

[TheFinalCD]

agree warrant price 1.10 and stock price in the $2's


doesnt make cents



PHIO
PHIOW

[The Other Guy]

Someone make a mistake with the warrants again? No reason price should rocket like it did without PHIO moving similarly.

[TheFinalCD]

.04 TO 1.10 NOE THATS CRAZEEEEEE


PHIOW

[The Other Guy]

Gerrit, where is the PH-762 ACT update? Today is the deadline. Show us you are worthy of the CEO title.

[ClayTrader]

* * $PHIO Video Chart 09-17-2020 * *

Link to Video - click here to watch the technical chart video

[The Other Guy]

Wrong board.

But I do see the PHIO CEO taking advantage of Covid to continue avoiding shareholders. No cc’s at earnings. No return emails. And now he is doing a virtual shareholder meeting. Gerrit should take a pay cut until he decides to produce for shareholders.

[The Other Guy]

We’re at discount pricing for the afternoon. Nothing in the earnings report should have us going into the red.

[The Other Guy]

Does Gerrit actually know how to run a public company? No clue when they will start the lead candidate clinical trials? Really?? And no earnings call for analysts and shareholders to ask questions?

PHIO will continue to burn cash, dilute shareholders and reverse split. But hey, at least he is excited they got three presentations in this quarter! What a joke Gerrit is as CEO.

[The Other Guy]

Another pump and dump. The company currently has nothing substantial in place. Geert gave it all up. Spending money on excessive salaries at this point.

[BEIJING BILL]

Theybare due fur news l2